MedPath

Therapeutic effects of manual therapy, transcutaneous electric nerval stimulation und forearm (extensor) brace on lateral epicondylopathia - a randomized controlled trial

Phase 4
Conditions
M77.1
Lateral epicondylitis
Registration Number
DRKS00021137
Lead Sponsor
Praxis für Allgemeinmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
52
Inclusion Criteria

Patients were included in the order they appeared at the practice with no pre-selection if they met the following criteria: (1) age between 18 and 65 years, (2) criteria for the diagnosis of a lateral epicondylitis needed to be fulfilled, (3) informed consent was given. Lateral epicondylopathia was diagnosed if (1) pain was reported for the lateral region of the elbow, (2) an extension of the hand joint provoked significant pain (provocation test), and (3) other diseases or injuries were excluded.

Exclusion Criteria

Patients were excluded from the study if they met at least one of the following criteria: injuries reported for the arm or cervical spine during the last 6 months, acute or chronic infections, rheumatic diseases, osteochondrosis dissecans, advanced osteoarthritis in the elbow, pregnancy, diabetes, malignoms, medication with beta blockers, medication with statins, malformation in upper extremities, circulatory disorder in upper extremities, radicular syndrome (C 6), chronic pain syndrome, manifest psychiatric disorder, neuropathy, myopathy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcomes were measured: Pain with VAS (visual analogous scale) and Range of Motion (ROM) of of the elbow joint in degrees before treatment (0) and in three follow ups 4, 8 weeks and 1 year later
Secondary Outcome Measures
NameTimeMethod
Secondary Outcomes were measured: Pain and Range of Motion with PRTEE (Patient Rated Tennis Elbow Evaluation Questionnaire) and psychosocial well-being with the Sf 36 (Short form 36 Questionnaire) before treatment (0) and in three follow ups 4, 8 weeks and 1 year later
© Copyright 2025. All Rights Reserved by MedPath